6-Thioguanine therapy for psoriasis causing toxic hepatic venoocclusive disease
Authors:
- Howard J. RosenblateHRHoward J. Rosenblate
- 1 June 1993
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 28 (6) , 1017-1018
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Effective early treatment of hepatic venoocclusive disease with a central splenorenal shunt in an infantJournal of Pediatric Surgery, 1992
- TREATMENT OF PSORIASIS WITH 6‐THIOGUANINEAustralasian Journal of Dermatology, 1988
- Azathioprine and hepatic venocclusive disease in renal transplant patientsGastroenterology, 1986
- Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing FactorsHepatology, 1984
- 6-Thioguanine as a cause of toxic veno-occlusive disease of the liverJournal of Clinical Pathology, 1982
- Hepatic Veno-Occlusive Disease Caused by 6-ThioguanineAnnals of Internal Medicine, 1982
- Veno-Occlusive Disease of the Liver After Allogeneic Bone Marrow TransplantationAnnals of Internal Medicine, 1979
- Veno-Occlusive Disease of the Liver After Chemotherapy of Acute LeukemiaAnnals of Internal Medicine, 1976
- Urethane-induced hepatic failure in manThe American Journal of Medicine, 1960
- Toxic Complications of Treatment with 6-MercaptopurineBMJ, 1960